Healthcare investor, entrepreneur, executive. Driven by curiosity. Devoted family man.

Joined January 2012
SHIH SHOOTS, SHIH SCORES🔥 📺 espn.com/watch/player/_/even… #HeresToIt x #GoTritons
1
1
6
384
Ken Lin retweeted
there’s a b2b company on here that basically uses hooters tactics as guerrilla marketing. it’s so loud, sexualized, & relentlessly in your face that even if i needed exactly what they were selling i’d probably hesitate to buy from them. which is kind of ironic cuz the marketing is incredibly effective at getting attention while simultaneously making the product feel less trustworthy overall.
86
10
4
649
90,929
Ken Lin retweeted
What happens when we believe in the power of small? Hear from a KiwiCo kid with the curiosity and creativity to find out... m.kiwico.com/AboutUs
3
3
17
Ken Lin retweeted
We challenged kids to build marble runs at home with the goal of connecting our community around the world one marble run at a time. In just a month, we received 700+ marble runs from 20+ countries. And now, we’re ready to reveal the full Mega Marble Run! kiwico.com/blog/2020/12/28/t…
1
2
Ken Lin retweeted
Last week, our Founder and CEO @SandraOhLin was featured on @HowIBuiltThis with @GuyRaz. They talk resilience during the pandemic and how KiwiCo has provided many families with resources and activities to promote learning at home. Listen here! #KiwiCo overcast.fm/+YsrY-NPxs
1
5
Congratulations, Andy!
We’re thrilled to learn that our co-founder Andrew Kruse has been promoted by Harvard to full professor with tenure, after only six years at the medical school. Andy is an expert on synthetic #antibodies and helped develop IPI’s antibody discovery platform. Congrats!
2
This is why we need aggressive adoption of protective measures ASAP. Please RT #COVIDー19
2
4
8
Yooooooooo! Congrats @JasonLettmann!!
Roche to acquire Promedior for $390M upfront + $1B milestone prnewswire.com/news-releases… Recombinant human Pentraxin-2 for IPF and MF
1
Our new paper is out today. We used CRISPR to uncover some really striking findings with several drugs and drug targets in clinical trials. Also, we accidentally found the first-ever inhibitor of the cyclin-dependent kinase CDK11. stm.sciencemag.org/content/1…
58
870
361
2,014
Congrats to two of the most thoughtful, honest, and courageous investors out there. Can’t wait to see what you do!
We’re excited to announce the launch of Vensana Capital and the close of our first fund at $225M — more here: businesswire.com/news/home/5…
1
1
11
Immensely proud of our full team from birth to today--was a thrilling and rewarding journey! Now, a happy and productive new home within @Ligand_LGND @timothyspringer @aaronmring @AashishManglik ligand.com/news-events/press…
5
Let’s play a little game. Let’s say that you’re the CSO at a cancer pharma company, and you have to choose a target to go after. Here’s a gene – high expression is associated with poor prognosis in brain cancer. Looks like a good candidate for an inhibitor right?
67
1,436
439
3,401
My good friend, adding to his long list of successes. It’s so deeply impressive to see someone repeatedly be so intimately involved with creating amazing things from mere seeds. Congratulations, buddy!
1
1
My dad just won the #Nobel prize for putting the red thingy into the blue thingy so it hooks on to the yellow thingy! #NobelPrize #phagedisplay #chemistry
2018 #NobelPrize laureate George Smith developed a method known as phage display, where a bacteriophage – a virus that infects bacteria – can be used to evolve new proteins.
121
2,784
237
11,671
BREAKING NEWS: The Royal Swedish Academy of Sciences has decided to award the #NobelPrize in Chemistry 2018 with one half to Frances H. Arnold and the other half jointly to George P. Smith and Sir Gregory P. Winter.
131
5,972
1,269
7,661